Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN118524 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Alanyl (Membrane) Aminopeptidase (ANPEP) antibody (FITC)
- Antibody type
- Monoclonal
- Antigen
- Human AML cells. Spleen cells from immunised BALB/c mice were fused with cells of the mouse NS1 myeloma cell line.
- Description
- Affinity Chromatography on Protein G?.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- WM15
- Vial size
- 0.1 mg
- Concentration
- 0.1 mg/mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light.
Submitted references The hepatobiliary disease marker serum alanine aminopeptidase predominantly comprises an isoform of the haematological myeloid differentiation antigen and leukaemia marker CD-13/gp150.
CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.
CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity.
Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.
Myeloid progenitor surface antigen identified by monoclonal antibody.
Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells.
Favaloro EJ, Browning T, Nandurkar H
Clinica chimica acta; international journal of clinical chemistry 1993 Oct 29;220(1):81-90
Clinica chimica acta; international journal of clinical chemistry 1993 Oct 29;220(1):81-90
CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated.
Favaloro EJ, Browning T, Facey D
Experimental hematology 1993 Dec;21(13):1695-701
Experimental hematology 1993 Dec;21(13):1695-701
CD-13 ('gp150'; aminopeptidase-N): co-expression on endothelial and haemopoietic cells with conservation of functional activity.
Favaloro EJ
Immunology and cell biology 1991 Aug;69 ( Pt 4):253-60
Immunology and cell biology 1991 Aug;69 ( Pt 4):253-60
Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.
Favaloro EJ, Bradstock KF, Kabral A, Grimsley P, Zowtyj H, Zola H
British journal of haematology 1988 Jun;69(2):163-71
British journal of haematology 1988 Jun;69(2):163-71
Myeloid progenitor surface antigen identified by monoclonal antibody.
Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Musgrove E
British journal of haematology 1985 Sep;61(1):11-20
British journal of haematology 1985 Sep;61(1):11-20
Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells.
Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Berndt MC, Musgrove E
Pathology 1985 Jul;17(3):392-9
Pathology 1985 Jul;17(3):392-9
No comments: Submit comment
No validations: Submit validation data